Tradestie Institutional Equity Comparison Engine

BOLD vs SNY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SNY Overall Edge

SNY Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BOLD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SNY at 8.6x Forward P/E and 22.3% operating margin (+15.7% YoY). In options structure, BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SNY sits in UNCLASSIFIED (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SNY
BOLD N/M vs SNY 8.6x Fwd P/E
Growth & Margin Winner SNY
Op Margin 0.0% vs 22.3% ยท YoY +0.0% vs +15.7%
Momentum & Technical Winner SNY
1Y +101.7% vs -6.1% ยท 52W Pos 62% vs 65%
Options & Structure Winner SNY
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (43rd %ile IV)
BOLD NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap $56.2M
1M Return -4.92%
1Y Return +101.74%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 25.0 Fund 50.0 Flow 50.0 Mom 60.0
SNY NASDAQ
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Pharmaceutical Preparations
$46.52
+1.0% 1D
Market Cap $110.6B
1M Return +10.87%
1Y Return -6.12%
Forward P/E 8.6x
Unified AI Score
40.3 / 100 SELL
Tech 32.0 Fund 43.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BOLD +101.74% SNY -6.12% Spread: +107.86 pp (BOLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BOLD TTM Op. Margin: 0.0% SNY TTM Op. Margin: 22.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BOLD vs SNY. Trailing 12-month operating profitability (BOLD 0.0% vs SNY 22.3%) and valuation multiples (BOLD N/M vs SNY 8.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BOLD (0) vs SNY (10)
Institutional Metric BOLD SNY Criterion Row Winner
Market Capitalization Scale $56.2M $110.6B Larger Scale SNY
Trailing P/E Ratio Valuation N/M 22.9x Lower Multiple SNY
Forward P/E Ratio Valuation N/M 8.6x Lower Multiple SNY
Revenue Growth (YoY) Growth +0.0% +15.7% Higher Growth SNY
Operating Margin (TTM) Profitability 0.0% 22.3% Higher Margin SNY
Net Profit Margin Profitability 0.0% 8.2% Higher Margin SNY
Return on Equity (ROE) Capital Efficiency -64.6% 5.7% Higher ROE SNY
52-Week Range Position Momentum 62% ($1โ€“$3) 65% ($39โ€“$51) Stronger Trend SNY
Beta / 30D Volatility Risk Regime -0.08ฮฒ ยท 28% Vol 0.20ฮฒ ยท 26% Vol Lower Realized Risk SNY
Unified Institutional Score Composite Signal 36.8 / 100 (SELL) 40.3 / 100 (SELL) Higher Composite SNY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BOLD vs SNY Buy Guide
BOLD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BOLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SNY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SNY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BOLD nor SNY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.